<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045021">
  <TermName>valdecoxib</TermName>
  <TermPronunciation>(VAL-deh-KOK-sib)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied as a treatment for pain and other side effects of cancer therapy. It belongs to the family of drugs called COX-2 inhibitors.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000706279" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;valdecoxib&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000706278" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;valdecoxib&quot;" language="es" id="_4"/>
  <SpanishTermName>valdecoxib</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del dolor y otros efectos secundarios de la terapia del c√°ncer. Es un tipo de inhibidor de COX-2.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
</GlossaryTerm>
